FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Desferal 2g powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metrolyl 1g suppositories (Sandoz Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desferrioxamine 2g powder for solution for injection vials 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flagyl 1g suppositories (Hawgreen Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution (Thornton & Ross Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desferrioxamine 2g powder for solution for injection vials (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Flagyl 1g suppositories (Hawgreen Ltd) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution (Thornton & Ross Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution (Thornton & Ross Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desferrioxamine 2g powder for solution for injection vials (Mayne Pharma Plc) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desferrioxamine 2g powder for solution for injection vials (Kent Pharma (UK) Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metrolyl 1g suppositories (Sandoz Ltd) 10 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desferrioxamine 2g powder for solution for injection vials (A A H Pharmaceuticals Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution (Unichem Plc) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desferrioxamine 2g powder for solution for injection vials (Kent Pharma (UK) Ltd) 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Desferal 2g powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution (A A H Pharmaceuticals Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodine aqueous oral solution (A A H Pharmaceuticals Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Botulinum toxin type B 2,500units/0.5ml solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Botulinum toxin type B 5,000units/1ml solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Botulinum toxin type B 10,000units/2ml solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Botulinum toxin type B 2,500units/0.5ml solution for injection vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
NeuroBloc 2,500units/0.5ml solution for injection vials (Medeus Pharma) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
NeuroBloc 5,000units/1ml solution for injection vials (Medeus Pharma) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Botulinum toxin type B 5,000units/1ml solution for injection vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
NeuroBloc 10,000units/2ml solution for injection vials (Medeus Pharma) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Botulinum toxin type B 10,000units/2ml solution for injection vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
NeuroBloc 2,500units/0.5ml solution for injection vials (Medeus Pharma) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
NeuroBloc 5,000units/1ml solution for injection vials (Medeus Pharma) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
NeuroBloc 10,000units/2ml solution for injection vials (Medeus Pharma) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 350mg/35ml solution for injection vials (Sandoz Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 350mg/35ml solution for injection vials (Sandoz Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/100ml rectal solution (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Flamingo Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Flamingo Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for concentrate for solution for infusion vials (medac UK) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/100ml rectal solution (Alliance Healthcare (Distribution) Ltd) 7 enema 7 x 100ml enemas VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Flamingo Pharma (UK) Ltd) 84 tablet 6 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Flamingo Pharma (UK) Ltd) 100 tablet 10 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Carmustine 100mg powder and solvent for concentrate for solution for infusion vials (medac UK) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 1.5million iu powder for infusion solution vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 250,000iu powder for infusion solution vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 750,000iu powder for infusion solution vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Streptase 750,000unit powder for solution for injection vials (Aventis Behring Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Streptase 1.5million unit powder for solution for injection vials (Aventis Behring Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Biofactor Streptokinase 250,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 250,000unit powder for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptase 250,000unit powder for solution for injection vials (Aventis Behring Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 1.5million unit powder for solution for infusion vials (Tetris Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 750,000unit powder for solution for injection vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 1.5million unit powder for solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Biofactor Streptokinase 1.5million unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 250,000unit powder for solution for infusion vials (Tetris Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Biofactor Streptokinase 750,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 750,000unit powder for solution for infusion vials (Tetris Pharma Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 750,000unit powder for solution for infusion vials (Tetris Pharma Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Streptase 750,000unit powder for solution for injection vials (Aventis Behring Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Streptase 1.5million unit powder for solution for injection vials (Aventis Behring Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Biofactor Streptokinase 750,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Biofactor Streptokinase 1.5million unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 250,000unit powder for solution for infusion vials (Tetris Pharma Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Biofactor Streptokinase 250,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptokinase 1.5million unit powder for solution for infusion vials (Tetris Pharma Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Streptase 250,000unit powder for solution for injection vials (Aventis Behring Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Salicylic acid 1.5% cream VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Norethisterone 200mg/1ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metanium Cradle Cap cream (William Ransom & Son Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noristerat 200mg/1ml solution for injection ampoules (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (Thornton & Ross Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Snufflebabe Cradle Cap cream (J Pickles Healthcare) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Salicylic acid 1.5% cream (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noristerat 200mg/1ml solution for injection ampoules (Schering Health Care Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Salicylic acid 1.5% cream 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (J M Loveridge Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Salicylic acid 1.5% cream 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Norethisterone 200mg/1ml solution for injection ampoules 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noristerat 200mg/1ml solution for injection ampoules (Schering Health Care Ltd) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (Thornton & Ross Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (Unichem Plc) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (A A H Pharmaceuticals Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metanium Cradle Cap cream (William Ransom & Son Plc) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Noristerat 200mg/1ml solution for injection ampoules (Waymade Healthcare Plc) 1 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Salicylic acid 1.5% cream (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Acetic acid 33% liquid (J M Loveridge Plc) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Snufflebabe Cradle Cap cream (J Pickles Healthcare) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely maprotiline hydrochloride 50 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Maprotiline 50mg tablets 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ludiomil 50mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 85 of 86 End

This concept is not in any reference sets

Back to Start